Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Jessen M, Gertzmann D, Liss F, Zenk F, et al. Oncogene 2024;43:578-593.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Jessen M, Gertzmann D, Liss F, Zenk F, et al. Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers. Oncogene 2024;43:578-593.
PMID: 38182898